Form D · Biotechnology

Redpoint Bio CORP

Philadelphia, PA · CIK 0001328003

Offering snapshot reported Jul 30, 2012 · SEC filing

Reported sold: $0
Investors reported: 40
Minimum accepted: $25K
First sale: Jul 16, 2012

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 30, 2012	Initial	$0	No comparison	40	SEC filing
May 19, 2005	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $3.5M (estimated)
Finders' fees: $0
Form D file number: 021-181937

*This is a best efforts offering on a minimum/maximum basis. The first subscription was received into escrow on July 16, 2012, but the minimum has not been reached and no shares have been issued pending receipt of at least the minimum amount.

*Represents maximum commission payable assuming the maximum offering amount is sold.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
National Securities Corporation	7569

Source: Form D, filed Jul 30, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Allen Bloom	Director
Robert Chefitz	Director
Horvitz Scott	Executive
Richard Shanley	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

5501 Old York Road
Philadelphia, PA, 19141